Description
CJC-1295 is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH), engineered with a Drug Affinity Complex (DAC) to extend its half-life significantly compared to native GHRH. It is studied in laboratory research for its ability to stimulate sustained growth hormone secretion and IGF-1 pathway activation from the anterior pituitary gland.
Molecular Formula: C₁₆₅H₂₆₉N₄₇O₄₆
Molecular Weight: 3,647.1 g/mol
CAS Number: 863288-34-0
Sequence Length: 30 amino acids
Form: Lyophilized powder
Vial Size: 3mL
Amount: 5mg
Purity: ≥99% (HPLC verified)
For research use only. Not intended for human or animal consumption.
COA
Third-party Certificate of Analysis available upon request. All batches are independently tested via HPLC and mass spectrometry to verify ≥99% purity prior to release.
Contact support@synpeptidesciences.com to request batch-specific COA documentation.
Storage
All SYN Sciences peptides are manufactured using the lyophilization (freeze-drying) process, ensuring stability during shipping for up to 3–4 months at room temperature.
Once reconstituted with bacteriostatic water, store refrigerated at 2–8°C (36–46°F) and use within 30 days.
For long-term storage (months to years), store lyophilized peptide in a freezer at -20°C to -80°C, away from light and moisture.
Keep all peptides away from direct sunlight and repeated freeze-thaw cycles.
Manufacturing Process
All SYN Sciences peptides are synthesized using Solid Phase Peptide Synthesis (SPPS) — the industry gold standard for research-grade peptide production.
Process overview:
– Amino acid chains assembled on solid resin support under controlled conditions
– Cleavage and deprotection performed using pharmaceutical-grade reagents
– Purified via high-performance liquid chromatography (HPLC) to ≥99% purity
– Identity confirmed by mass spectrometry (MS)
– Screened for heavy metals and endotoxins
– Lyophilized (freeze-dried) and nitrogen-sealed in sterile vials for maximum stability
Every batch undergoes independent third-party quality verification before release.
Research
CJC-1295 is studied in laboratory research settings for its role in growth hormone axis regulation and pituitary function modeling. Research applications include:
– Growth hormone-releasing hormone (GHRH) receptor binding studies
– Sustained GH secretion and pulsatility modeling
– IGF-1 pathway activation and downstream signaling research
– Anterior pituitary somatotroph function studies
– Metabolic regulation and body composition research models
– Drug Affinity Complex (DAC) pharmacokinetic studies
– Long-acting GHRH analogue behavior in preclinical models
All references to biological activity are provided for scientific context only and do not constitute claims of therapeutic benefit. This product is not approved for human or animal use.
